Skip to main content
CELL BIOTECH CO ., LTD logo

CELL BIOTECH CO ., LTD — Investor Relations & Filings

Ticker · 049960 ISIN · KR7049960008 KO Manufacturing
Open in API
Filings indexed 189 across all filing types
Latest filing 2023-11-08 Earnings Release
Country KR South Korea
Listing KO 049960

About CELL BIOTECH CO ., LTD

https://www.cellbiotech.com/

CELL BIOTECH CO., LTD. is a biotechnology company specializing in the research, development, and manufacturing of probiotic solutions. With over three decades of experience, the company leverages its proprietary, worldwide-patented dual-coating technology, which is designed to ensure a higher survival rate for probiotic strains as they pass through the gastrointestinal tract. The company develops and utilizes its own GRAS (Generally Recognized as Safe) certified strains for its products. Its business encompasses the production of finished consumer products, such as the DUOLAC brand, and providing customized OEM/ODM services for the pharmaceutical and food supplement sectors.

Recent filings

Filing Released Lang Actions
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a preliminary earnings release (잠정실적) for Cell Biotech, detailing quarterly financial performance (revenue, operating profit, net income) for the 3rd quarter of 2023. It follows the standard format for an initial earnings announcement, which provides key financial highlights before the full audit is completed. This fits the definition of an Earnings Release (ER). Q3 2023
2023-11-08 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '쎌바이오텍' (Cell Biotech) covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial information, business operations, management discussions, and corporate governance details, which are characteristic of an interim/quarterly financial report. It is not a mere announcement or certification, as it contains substantive financial and operational data. H1 2023
2023-08-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Preliminary Earnings Release' (영업(잠정)실적) for Cell Biotech. It provides key financial highlights such as revenue, operating profit, and net income for the second quarter of 2023. It is a short, structured announcement of financial results rather than a full quarterly report or a report publication announcement. Therefore, it fits the definition of an Earnings Release (ER). H1 2023
2023-08-04 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding the scheduling of an Investor Relations (IR) meeting (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an upcoming event rather than the presentation materials themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2023-06-05 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '쎌바이오텍' (Cell Biotech) covering the period from 2023-01-01 to 2023-03-31. It contains detailed business information, product data, and operational disclosures typical of a quarterly financial filing. According to the provided definitions, a comprehensive financial report for a period shorter than a full fiscal year is classified as an Interim / Quarterly Report (IR). Q1 2023
2023-05-15 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Cell Biotech, detailing quarterly financial performance (revenue, operating profit, net income) for 2023 Q1. It provides key financial highlights and comparisons to previous periods, which is the standard format for an Earnings Release (ER). It is not a full report, but rather the initial announcement of financial results. Q1 2023
2023-05-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.